Seamless Therapeutics Announces Global Research Collaboration With Lilly To Develop Programmable Recombinase-Based Therapeutics For Hearing Loss

(MENAFN - GlobeNewsWire - Nasdaq) -- Collaboration will advance a next generation gene editing approach by combining Seamless' expertise in developing highly precise and efficient recombinases ...